ArticleJournal of patient-reported outcomes2026
Confirmation of unidimensionality of the Dermatology Life Quality Index (DLQI) using a multinational 3,408 patient dataset.
Article in Journal of patient-reported outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Dermatology Life Quality Index (DLQI) was designed to be a simple, practical questionnaire for routine clinical use and is the most widely used tool to measure the burden of skin diseases and assess effectiveness of interventions based on patients’ perspective. The aim of this study was to further validate the DLQI using a multinational European study dataset.
methodsData from a cross-sectional study conducted in 13 European countries were analysed. In each dermatology clinic, 250 consecutive adult out-patients were recruited. A wide range of classical test theory and IRT tools were used to investigate unidimensionality and known-group properties.
resultsFrom 3,635 patients, 3408 completed the DLQI with no missing data. 55.8% of patients were female, mean age 46.6 years (SD = 17.82). The commonest conditions were psoriasis (17.4%), non-melanoma skin cancer (10.8%), infection of the skin (6.7%), hand eczema (6.2%) and acne (6.2%). Using DLQI score banding, the patients’ disease had no effect (n = 962, 28.2%), small (912, 26.8%), moderate (674, 19.8%), very large (691, 20.3%) or extremely large effect (169, 5.0%) on their quality of life. Psychometric analyses employing eigenvalues, scree plots, item-response theory (IRT) and very simple structure indicated unidimensionality. Cumulative explained common variance did not significantly increase from 0.618 with additional factors. Confirmatory factor analysis fits for a 1-factor solution were very good and a 1-factor model was optimum. IRT indicated good fit statistics, no misfitting items (infit and outfit), and no local dependencies (LG2 and Q3). Cronbach’s alpha was 0.90. Cohen’s-d effect sizes for DLQI scores between different EQ-5D item levels were moderate (> 0.5) or large (> 0.8), and large between different disease severity levels. Good correlation was found between EQ-5D VAS scale and DLQI score (r2 =-0.409, p < 0.001). Known group analysis of DLQI score by severity was significant between groups (p < 0.001).
conclusionAnalysis showed good psychometric properties confirming a 1-factor unidimensional model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.